HIV-1 drug resistance and associated risk factors in patients with antiretroviral therapy failure in Chongqing, China, 2019-2023. [PDF]
Zhang H, Wu P, Ye W.
europepmc +1 more source
Enzyme Selectivity of HIV Reverse Transcriptase: Conformations, Ligands, and Free Energy Partition. [PDF]
Kirmizialtin S, Johnson KA, Elber R.
europepmc +1 more source
Virtual Screening of FDA-Approved Compounds: Exploring New Alternatives for HIV Treatment. [PDF]
Martinez DP, Kremer FS.
europepmc +1 more source
Protease-mediated maturation of M-PMV reverse transcriptase into a functional heterodimer. [PDF]
Kapisheva M +6 more
europepmc +1 more source
Marine-Derived Defenses Against HIV: Emerging Bioactive Molecules from the Seas. [PDF]
Santos T +3 more
europepmc +1 more source
Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings? [PDF]
Gupta S +7 more
europepmc +1 more source
Modeling NRTIs and PIs class drug therapy on the dynamics of HIV infection with real patient data analysis and optimized control strategy. [PDF]
Sardar P +6 more
europepmc +1 more source
Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies. [PDF]
Cox S +7 more
europepmc +1 more source
National representative survey of pretreatment HIV drug resistance in Colombia: analysis of antiretroviral resistance-associated mutations using next-generation sequencing. [PDF]
Martínez-Buitrago E +10 more
europepmc +1 more source
Characterization of drug resistance mutations in people living with HIV with low-level viremia on antiretroviral therapy in Chongqing, China. [PDF]
Zhang H, Zhang Z, Ye W, Pan W.
europepmc +1 more source

